REYN:NASDAQReynolds Consumer Products Inc. Analysis
Data as of 2026-04-28 - not real-time
$20.84
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Reynolds Consumer Products is trading at $20.84, which sits below its 20‑day (21.47), 50‑day (22.17) and 200‑day (23.13) simple moving averages, signaling a bearish short‑term momentum. The RSI of 39 points to a near‑oversold condition, while the MACD histogram remains negative, and the stock is hovering just above the identified support level of $20.70 with resistance near $22.52. Volume has been increasing, hinting at growing participation despite the downtrend.
Fundamentally, the company delivers modest revenue growth of 1.4% and healthy operating margins (17.9%). Forward earnings per share are projected at $1.70, yielding a forward PE of 12.3, and the dividend yield stands at an attractive 4.41% with a 64% payout ratio backed by $291 million of free cash flow. Though leverage is elevated (Debt/Equity ≈ 75%), the stock benefits from a low beta (0.5) and moderate 30‑day volatility (20.5%). Analysts’ consensus targets average $25.14, implying ~20% upside, while the market’s extreme greed sentiment (Fear & Greed Index 89.25) adds momentum to the upside narrative.
Fundamentally, the company delivers modest revenue growth of 1.4% and healthy operating margins (17.9%). Forward earnings per share are projected at $1.70, yielding a forward PE of 12.3, and the dividend yield stands at an attractive 4.41% with a 64% payout ratio backed by $291 million of free cash flow. Though leverage is elevated (Debt/Equity ≈ 75%), the stock benefits from a low beta (0.5) and moderate 30‑day volatility (20.5%). Analysts’ consensus targets average $25.14, implying ~20% upside, while the market’s extreme greed sentiment (Fear & Greed Index 89.25) adds momentum to the upside narrative.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near technical support at $20.70
- RSI indicating near‑oversold condition
- Upcoming earnings release on May 6
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Analyst consensus target of $25.14 (~20% upside)
- Strong dividend yield of 4.41% with sustainable payout
- Improving forward earnings and low beta
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Stable cash flow generation supporting dividend
- Defensive consumer‑cyclical positioning
- Low market sensitivity (beta 0.5) and moderate volatility
Key Metrics & Analysis
Financial Health
Revenue Growth1.40%
Profit Margin8.09%
P/E Ratio14.6
ROE13.70%
ROA6.78%
Debt/Equity75.37
P/B Ratio1.9
Op. Cash Flow$477.0M
Free Cash Flow$291.0M
Technical Analysis
TrendBearish
RSI39.2
Support$20.70
Resistance$22.52
MA 20$21.47
MA 50$22.17
MA 200$23.13
MACDBearish
VolumeIncreasing
Fear & Greed Index89.25
Valuation
Fair Value$12.46
Target Price$25.14
Upside/Downside20.65%
GradeFair
TypeBlend
Dividend Yield4.41%
Risk Assessment
Beta0.50
Volatility20.50%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.